GR

Greg Roumeliotis

Corporate Finance & ESG Editor at Reuters

Covers

Publications

  • reuters.com
    2 articles
  • Reuters
    2 articles
  • yahoo.com
    1 article
  • yahoo.com
    1 article

Writes Most On

PrivateEquityReutersMarketCapitalizationOperatorNewYorkMentalHealthAcadiaKohlbergKravisRobertsAddictionHealthCareSubstanceAbuseLondonPuertoRicoInsuranceUnitedStatesKKRSanFranciscoFranklinTennesseeStakePatentsMalikieInnovationsFinancialAdvisorsGovernmentFocusedFredAndersonCitadelCOVID19VaccinesSilverLakePartnersAppleIncPotentialBuyersNucleicAcidProductionCuscoBlackHawkBusinessesElevationPartnersInternetOfThingsMRNAVaccinesStarGuitarInitialPublicOfferingMaravaiLifeSciencesIPOThomsonReutersMortgageLoanSartoriusAGMachuPicchuSoftwareStrategicReviewCybersecuritySoftwareGuruOffer
  • Private equity firm Veritas makes takeover offer for BlackBerry -source
    25 Aug 2023—yahoo.com
    By Greg Roumeliotis (Reuters) -Private equity firm Veritas Capital has made an offer to buy BlackBerry Ltd, according to a person familiar with the matter, months after the Canadian technology company began a strategic review. U.S-listed shares of BlackBerry, which earlier rose about 17% on the news, closed at $5.23, giving the company a market capitalization of $3.1 billion. Details of the offer could not be learned. Veritas and Blackberry did not immediately respond to Reuters requests for...
  • Exclusive-Vaccine reagent vendor Maravai draws private equity interest-sources
    16 May 2023—yahoo.com
    By Greg Roumeliotis NEW YORK (Reuters) - Maravai LifeSciences Holdings Inc, a provider of capping reagents for COVID-19 vaccines whose shares plunged after the pandemic eased, has attracted private equity interest, people familiar with the matter said. Buyout firm Thomas H. Lee Partners has approached Maravai, which has a market capitalization of about $3.8 billion, with a non-binding offer, the sources said. The price offered could not be learned. Maravai rejected the offer, and there is no...

People Also Viewed